查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1763311

全球微波消融市場

Microwave Ablation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球微波消融市場規模將達到 5.712 億美元

全球微波消融市場規模預計在2024年達到2.712億美元，預計在分析期內（2024-2030年）將以13.2%的複合年成長率成長，到2030年將達到5.712億美元。肝癌是本報告分析的細分市場之一，預計其複合年成長率將達到15.2%，到分析期結束時將達到2.155億美元。乳癌細分市場在分析期間內的複合年成長率預計為11.7%。

美國市場規模估計為 6,900 萬美元，中國市場預計複合年成長率為 17.3%

美國微波消融市場規模預計在2024年達到6,900萬美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到1.405億美元，在2024-2030年的分析期間內，複合年成長率為17.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為8.9%和11.2%。在歐洲，預計德國市場的複合年成長率為10.2%。

全球微波消融市場－主要趨勢與促進因素摘要

什麼是微波消融？為什麼它在現代醫學中如此重要？

微波消融術 (MWA) 是一種微創醫療技術，利用電磁波產生熱量並破壞異常組織，主要是腫瘤。在這種治療方法中，將一根細針狀探針插入目標組織，透過探針發射微波產生局部熱能。這種熱會誘導目標組織細胞死亡，有效破壞癌細胞或異常細胞，同時不損傷周圍的健康組織。微波消融術廣泛用於治療各種癌症，包括肝癌、腎臟癌、肺癌和骨腫瘤，以及其他軟組織異常。

微波消融術已成為現代醫學，尤其是腫瘤學的重要工具，因為它能夠提供有效的治療並且恢復時間最短。與傳統手術相比，微波消融術侵入性較小，可在門診進行，且併發症發生率較低。對於因高齡、健康狀況不佳或腫瘤位置不適合手術的患者，微波消融術是一種特別有價值的治療方法。微波消融術的精確度及其在難以觸及的位置治療各種大小腫瘤的能力使其成為癌症治療方法中一種多功能且重要的技術。隨著全球癌症發生率持續上升，微波消融術為傳統治療方法提供了一種創新、有效且侵入性較小的治療方法。

微波消融的主要應用有哪些？具體的醫療需求有哪些？

微波消融主要用於治療癌症，尤其是肝臟、肺部、腎臟和骨骼腫瘤。在肝細胞癌 (HCC) 中，微波消融 (MWA) 用於靶向因大小、數量或位置原因而無法手術切除的腫瘤。微波消融通常被用作早期肝癌患者的手術替代方案，或晚期腫瘤患者的姑息治療。該技術能夠以精確可控的方式摧毀腫瘤，使其在肝癌治療中特別有效，因為在肝癌治療中，保留健康的肝組織至關重要。 MWA 也能有效治療其他部位癌症（例如大腸直腸癌）引起的肝轉移，這進一步擴展了其在腫瘤學中的應用。

肺癌是微波消融發揮重要作用的另一個領域。對於不適合手術或有其他原發性癌症肺轉移的早期非小細胞肺癌 (NSCLC) 患者，MWA 是一種微創治療選擇。這種治療方法可以精確地瞄準肺癌腫瘤，同時避免損傷周圍肺組織。這使其成為肺功能受損或無法耐受更具侵入性手術的患者的理想選擇。除了肺癌和肝癌之外，微波消融擴大用於治療方法腎臟腫瘤，尤其是不適合腎切除術或部分切除術的患者的小腎腫塊。 MWA 的精確性允許有針對性的腫瘤破壞，同時盡可能保留腎功能。

微波消融也用於治療骨轉移，即癌細胞從其他器官的原發性腫瘤擴散至骨骼。骨轉移會引起劇烈疼痛和結構性損傷，最終導致骨折和生活品質下降。微波消融透過破壞骨頭內的腫瘤組織，提供了一種有效的止痛和穩定骨骼的方法。它通常與其他治療方法（例如放射療法和全身療法）合併使用，以改善轉移性骨病患者的預後。此外，微波消融也正在探索應用於其他軟組織腫瘤，例如腎上腺腺癌、甲狀腺癌和前列腺癌，從而拓寬其在腫瘤學中的潛在應用。

除了腫瘤科，微波消融術也用於治療良性腫瘤和某些非癌性疾病。例如，微波消融術 (MWA) 用於治療引起不適、吞嚥困難和影響美觀的良性甲狀腺結節。透過切除結節組織，MWA 可以縮小結節並緩解症狀，無需進行侵入性手術。同樣，微波消融術也用於治療良性前列腺增生 (BPH)。在這種情況下，MWA 可用於縮小前列腺並緩解泌尿系統症狀，為傳統外科手術提供了微創替代方案。

微波消融的多功能性不僅限於腫瘤治療；其在心血管疾病的應用也正在探索中。微波消融透過消融導致心率的異常心臟組織來治療心律不整的能力也正在研究中。隨著微波消融應用研究的進展，預計其應用範圍將擴展到更廣泛的醫療狀況，以鞏固其作為微創治療重要工具的地位。

科技進步如何影響微波消融市場？

技術進步顯著提高了微波消融的療效、準確性和安全性，使其成為越來越受臨床醫生和患者青睞的治療選擇。微波消融技術的一大進展是開發了更先進的多探頭系統，可以同時消融多個腫瘤。這對於多灶性疾病患者（例如多發性肝轉移或肺結節）尤其重要。使用多個探頭使臨床醫生能夠在一次治療中治療更大面積或多個腫瘤，從而減少再次治療的需要並提高整體治療效率。這些多探頭系統還能更均勻地加熱目標組織，有效地摧毀整個腫瘤。

除了多探頭系統外，即時成像和導引技術的進步也顯著提高了微波消融手術的精確度。超音波、電腦斷層掃描 (CT) 和磁振造影(MRI) 等高解析度顯像模式現已與消融系統結合，可即時顯示治療部位。這使臨床醫生能夠精確定位消融探頭並監測手術進展，確保完全切除腫瘤，同時最大限度地減少對周圍健康組織的傷害。即時回饋也有助於調整微波能的功率和持續時間，提高手術的安全性和有效性。這些影像處理的進步對於治療位於血管和重要器官等關鍵結構附近的腫瘤尤其有價值。

另一項重要的技術發展是微波消融探頭的改進。現代消融探頭設計得更薄、更靈活、更耐用，使其更容易插入體內，並在狹窄或難以觸及的區域更靈活地操作。使用更小、更靈活的探頭可以降低出血和感染等併發症的風險，並提高患者在手術期間和術後的舒適度。此外，消融探頭冷卻機制的進步提高了散熱效率，從而可以在不使周圍組織過熱的情況下輸送高功率。這些探頭設計的改進使微波消融成為一種更安全、更有效的治療方法，尤其適用於腫瘤位於脆弱或難以觸及的區域的患者。

在腫瘤學領域，微波消融與免疫療法和化療等其他治療方法的聯合研究，為提升癌症治療效果開闢了新的可能性。微波消融與全身性治療相結合，可以增強針對腫瘤的免疫反應，或透過破壞癌細胞使其更易受藥物攻擊來增強化療的療效。這種協同療法或可為晚期或難治性癌症患者提供更全面、更有效的治療策略。探索此類聯合治療的臨床試驗正在進行中，早期結果表明，它們可能在未來的癌症治療中發揮重要作用。

數據分析和人工智慧 (AI) 的進步也開始影響微波消融市場。 AI主導的軟體工具正在開發中，以協助臨床醫生規劃和最佳化消融程序。這些工具可以分析患者數據，包括腫瘤大小、位置和周圍解剖結構，從而推薦最合適的消融參數和探頭位置。透過根據患者個體特徵提供個人化治療方案，AI 有助於確保手術量身定做，以實現最佳療效。此外，基於 AI 的工具還可以透過分析影像資料來檢測殘留腫瘤組織和潛在併發症，從而輔助術後監測，從而改善患者的長期預後。

最後，可攜式微波消融系統的進步正在擴大這項技術的可近性，尤其是在門診病人和小型醫療機構。可攜式消融設備結構緊湊，易於運輸，可安裝在各種醫療環境中，使更多患者受益於此治療方法。隨著醫療保健系統越來越重視成本效益高、微創的治療，可攜式微波消融系統的普及率預計將不斷提高，使這項技術在都市區醫療機構中得到更廣泛的應用。

推動微波消融市場成長的因素是什麼？

微波消融市場的成長受到多種關鍵因素的推動，包括全球癌症發病率的上升、對微創治療的日益偏好以及提高手術安全性和有效性的技術進步。其中一個主要因素是全球癌症發生率的上升。根據世界衛生組織 (WHO) 的數據，癌症仍然是全球最大的死亡原因，每年有數百萬個新診斷的癌症病例。隨著癌症患者數量的持續增加，對能夠改善治療效果同時最大限度地減少副作用的治療方法的需求也日益增加。對於許多患者，尤其是那些患有無法手術的腫瘤或尋求微創治療方法的患者，微波消融為傳統手術的一種有吸引力的替代方案。

人們對微創手術日益成長的偏好也是推動微波消融市場成長的關鍵因素。患者和醫療保健提供者都在尋求比傳統開放性手術恢復更快、併發症更少、住院時間更短的治療方法。微波消融術符合這些標準，因為它可以在門診病人進行，通常在局部麻醉下進行，通常可以減輕疼痛並更快地恢復正常活動。這種微創治療的趨勢在腫瘤學領域尤其明顯，微波消融術為更積極的手術方法提供了一種替代方案，尤其適用於早期癌症患者或因潛在疾病而不適合手術的患者。

微波消融系統的技術進步也推動了市場成長，因為它提高了手術的精確度、安全性和有效性。隨著新的影像和引導技術提高臨床醫生精準瞄準腫瘤並避開健康組織的能力，微波消融的應用正在不斷擴大。此外，更強大、更有效率的消融設備的發展，加上即時監測功能，使得手術在更廣泛的腫瘤類型和大小範圍內更容易獲得和有效。這些技術創新正在推動微波消融在醫院和門診的普及，從而促進整體市場的成長。

微波消融作為某些癌症一線治療手段的日益普及和認可，也促進了市場擴張。臨床醫師逐漸意識到微波消融在治療難以觸及或靠近重要組織的腫瘤方面的價值，而這些腫瘤對傳統手術而言風險很高。微波消融能夠治療肝臟、肺部、腎臟和骨骼等多個器官的腫瘤，使其成為治療各種癌症的多功能選擇。此外，隨著越來越多的臨床研究證明微波消融在治療多種腫瘤方面的安全性和有效性，它正逐漸被接受成為一種標準治療方法。

人口老化以及肝病、腎病和肺病等慢性疾病的盛行率不斷上升，進一步推動了微波消融的需求。隨著全球人口老化，肝硬化和肝炎等可能導致腫瘤發展的疾病的發生率也在上升。對於許多老年患者和患有併發症的患者來說，與更激進的外科手術相比，微波消融是一種更安全、創傷更小的選擇。慢性病和合併症患者數量的增加預計將推動微波消融在腫瘤學和其他治療領域的進一步應用。

總而言之，受全球癌症發病率上升、微創治療需求成長以及持續提升手術安全性、準確性和有效性的技術進步的推動，微波消融市場有望迎來顯著成長。隨著醫療保健提供者持續重視以患者為中心且經濟高效的治療方案，預計未來幾年微波消融的需求將蓬勃發展，其在癌症治療及其他領域的作用也將進一步擴大。

部分

應用（肝癌、乳癌、肺癌、攝護腺癌、其他應用）

受訪公司範例

  • Angio Dynamics
  • Boston Scientific Corporation
  • Emblation microwave
  • Huber+Suhner
  • Johnson & Johnson Services Inc.
  • Med Waves
  • Medtronic PLC
  • MedWaves Inc.
  • Miramar labs
  • Neu Wave Medical
  • Pearson Medical
  • Symple Surgical
  • Urologix
  • Vison Medical USA Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP17289

Global Microwave Ablation Market to Reach US$571.2 Million by 2030

The global market for Microwave Ablation estimated at US$271.2 Million in the year 2024, is expected to reach US$571.2 Million by 2030, growing at a CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the analysis period. Growth in the Breast Cancer segment is estimated at 11.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$69.0 Million While China is Forecast to Grow at 17.3% CAGR

The Microwave Ablation market in the U.S. is estimated at US$69.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$140.5 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.9% and 11.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

Global Microwave Ablation Market - Key Trends & Drivers Summarized

What Is Microwave Ablation, And Why Is It Crucial in Modern Medical Treatments?

Microwave ablation (MWA) is a minimally invasive medical procedure that uses electromagnetic waves to generate heat and destroy abnormal tissue, primarily tumors. The procedure involves the insertion of a thin, needle-like probe into the target tissue, through which microwaves are transmitted to create localized thermal energy. This heat induces cellular death in the targeted tissue, effectively destroying cancerous or abnormal cells while sparing the surrounding healthy tissue. Microwave ablation is widely used in the treatment of various cancers, including liver, kidney, lung, and bone tumors, as well as other soft-tissue abnormalities.

Microwave ablation is a crucial tool in modern medicine, particularly in oncology, due to its ability to offer effective treatment with minimal recovery time. Compared to traditional surgery, MWA is less invasive, can be performed on an outpatient basis, and is associated with lower complication rates. It is especially valuable for patients who are not candidates for surgery due to advanced age, poor health, or the location of the tumor. MWA’s precision and ability to treat tumors of varying sizes in hard-to-reach areas make it a versatile and vital technology in cancer treatment. As the global incidence of cancer continues to rise, microwave ablation offers an innovative, effective, and less invasive alternative to more traditional treatment modalities.

What Are the Main Applications of Microwave Ablation, And How Does It Serve Specific Medical Needs?

Microwave ablation is applied primarily in the treatment of cancerous tumors, particularly in patients with liver, lung, kidney, and bone tumors. In hepatocellular carcinoma (HCC), or liver cancer, MWA is used to target tumors that are not suitable for surgical resection due to their size, number, or location. Microwave ablation is often employed as an alternative to surgery for patients with early-stage liver cancer or as a palliative treatment for those with advanced-stage tumors. The technology’s ability to destroy tumors in a precise and controlled manner makes it particularly useful in liver cancer treatment, where preserving healthy liver tissue is critical. MWA is also effective in treating liver metastases from cancers originating in other parts of the body, such as colorectal cancer, further expanding its applications in oncology.

Lung cancer is another area where microwave ablation plays a significant role. For patients with early-stage non-small cell lung cancer (NSCLC) who are not candidates for surgery or those with lung metastases from other primary cancers, MWA offers a minimally invasive treatment option. The procedure allows for the precise targeting of lung tumors while avoiding damage to surrounding lung tissue. This makes it an ideal treatment for patients with compromised lung function or those unable to tolerate more invasive procedures. In addition to lung and liver cancer, microwave ablation is increasingly used to treat renal (kidney) tumors, particularly small renal masses in patients who may not be suitable for nephrectomy or partial nephrectomy. The precise nature of MWA allows for targeted tumor destruction, while preserving as much kidney function as possible.

Microwave ablation is also used in the treatment of bone metastases, where cancer cells spread to the bones from primary tumors in other organs. Bone metastases can cause significant pain and structural damage, leading to fractures and reduced quality of life. MWA provides an effective way to manage pain and stabilize bones by destroying tumor tissue within the bone. It is often combined with other therapies, such as radiation or systemic treatments, to improve outcomes for patients with metastatic bone disease. Furthermore, microwave ablation is being explored for use in other soft tissue tumors, such as adrenal, thyroid, and prostate cancers, expanding its potential applications in oncology.

Outside of oncology, microwave ablation has applications in the treatment of benign tumors and certain non-cancerous conditions. For example, MWA is used to treat benign thyroid nodules, which can cause discomfort, difficulty swallowing, or cosmetic concerns. By ablating the nodular tissue, MWA reduces the size of the nodule and alleviates symptoms without the need for more invasive surgery. Similarly, microwave ablation is used in the treatment of benign prostatic hyperplasia (BPH), a common condition in aging men characterized by an enlarged prostate. In these cases, MWA can be used to shrink the prostate and relieve urinary symptoms, offering a minimally invasive alternative to traditional surgical procedures.

The versatility of microwave ablation extends beyond tumor treatment, as it is also being researched for its potential use in managing cardiovascular conditions. Studies are exploring MWA’s ability to treat arrhythmias by ablating abnormal heart tissue that causes irregular heartbeats. As research into MWA’s applications continues, its use in a broader range of medical conditions is expected to expand, solidifying its position as a critical tool in minimally invasive medical treatments.

How Are Technological Advancements Impacting the Microwave Ablation Market?

Technological advancements are driving significant improvements in the efficacy, precision, and safety of microwave ablation, making it an increasingly attractive option for both clinicians and patients. One of the key advancements in microwave ablation technology is the development of more sophisticated, multi-probe systems that allow for the simultaneous ablation of multiple tumors. This is particularly important for patients with multifocal disease, such as those with multiple liver metastases or lung nodules. By using multiple probes, clinicians can treat larger areas or multiple tumors in a single session, reducing the need for repeat procedures and improving overall treatment efficiency. These multi-probe systems also allow for more uniform heating of the targeted tissue, ensuring that the entire tumor is effectively destroyed, which is crucial for reducing the risk of recurrence.

In addition to multi-probe systems, advancements in real-time imaging and guidance technologies are significantly enhancing the precision of microwave ablation procedures. High-resolution imaging modalities, such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), are being integrated with ablation systems to provide real-time visualization of the treatment area. This allows clinicians to accurately position the ablation probe and monitor the progress of the procedure, ensuring that the tumor is completely ablated while minimizing damage to surrounding healthy tissue. Real-time feedback also helps in adjusting the power and duration of microwave energy delivery, enhancing the safety and effectiveness of the procedure. These imaging advancements are particularly valuable for treating tumors located near critical structures, such as blood vessels or vital organs.

Another significant technological development is the refinement of microwave ablation probes. Modern ablation probes are designed to be thinner, more flexible, and more durable, making them easier to insert into the body and allowing for better maneuverability within tight or difficult-to-access areas. The use of smaller, more flexible probes reduces the risk of complications, such as bleeding or infection, and improves patient comfort during and after the procedure. Additionally, advancements in the cooling mechanisms of ablation probes have improved their efficiency in dissipating heat, allowing for higher power delivery without overheating surrounding tissues. These improvements in probe design are making microwave ablation safer and more effective, particularly for patients with tumors in delicate or challenging locations.

In the field of oncology, research into combining microwave ablation with other treatment modalities, such as immunotherapy and chemotherapy, is opening new possibilities for enhancing cancer treatment outcomes. Combining MWA with systemic therapies may improve the immune response to tumors or increase the effectiveness of chemotherapy by disrupting tumor cells and making them more vulnerable to drugs. This synergistic approach has the potential to offer more comprehensive and effective treatment strategies for patients with advanced or difficult-to-treat cancers. Clinical trials are ongoing to explore these combinations, and early results suggest that they could play an important role in the future of cancer care.

Advances in data analytics and artificial intelligence (AI) are also starting to impact the microwave ablation market. AI-driven software tools are being developed to assist clinicians in planning and optimizing ablation procedures. These tools can analyze patient data, including tumor size, location, and surrounding anatomy, to recommend the most appropriate ablation parameters and probe placement. By providing personalized treatment plans based on individual patient characteristics, AI can help ensure that the procedure is tailored to achieve the best possible outcome. Additionally, AI-based tools can assist in post-procedure monitoring by analyzing imaging data to detect residual tumor tissue or potential complications, improving long-term outcomes for patients.

Finally, advancements in portable microwave ablation systems are expanding the accessibility of this technology, particularly in outpatient settings and smaller medical facilities. Portable ablation units are compact, easy to transport, and can be set up in various healthcare environments, making it possible for more patients to benefit from this treatment option. As healthcare systems increasingly prioritize cost-effective and minimally invasive treatments, the availability of portable microwave ablation systems is expected to grow, enabling wider adoption of this technology in both urban and rural healthcare settings.

What Is Driving the Growth in the Microwave Ablation Market?

The growth in the microwave ablation market is driven by several key factors, including the rising global incidence of cancer, the increasing preference for minimally invasive treatments, and technological advancements that enhance the safety and efficacy of the procedure. One of the primary drivers is the growing burden of cancer worldwide. According to the World Health Organization (WHO), cancer remains a leading cause of death globally, with millions of new cases diagnosed each year. As the number of cancer patients continues to rise, there is increasing demand for effective treatment options that offer improved outcomes with minimal side effects. Microwave ablation provides an attractive alternative to traditional surgery for many patients, particularly those with inoperable tumors or those seeking less invasive treatment options.

The increasing preference for minimally invasive procedures is another significant factor contributing to the growth of the microwave ablation market. Patients and healthcare providers alike are seeking treatments that offer faster recovery times, fewer complications, and reduced hospital stays compared to traditional open surgeries. Microwave ablation fits these criteria, as it can be performed on an outpatient basis, often under local anesthesia, and typically results in less pain and a quicker return to normal activities. This trend toward minimally invasive treatments is particularly strong in oncology, where microwave ablation offers an alternative to more aggressive surgical approaches, especially for patients with early-stage cancers or those who are not candidates for surgery due to underlying health conditions.

Technological advancements in microwave ablation systems are also driving market growth by improving the precision, safety, and efficacy of the procedure. As new imaging and guidance technologies enhance the ability of clinicians to target tumors accurately and avoid healthy tissue, the adoption of microwave ablation is expanding. Furthermore, the development of more powerful and efficient ablation devices, combined with real-time monitoring capabilities, is making the procedure more accessible and effective across a wider range of tumor types and sizes. These technological innovations are helping to increase the adoption of microwave ablation in both hospital and outpatient settings, contributing to the overall growth of the market.

The increasing awareness and adoption of microwave ablation as a first-line treatment for certain cancers is also contributing to market expansion. Clinicians are recognizing the value of MWA for treating tumors that are difficult to access or located near critical structures, where traditional surgery may pose a higher risk. The ability of microwave ablation to treat tumors in multiple organs, including the liver, lungs, kidneys, and bones, makes it a versatile option in the treatment of various cancers. Additionally, as more clinical studies demonstrate the safety and efficacy of MWA in treating a wide range of tumors, its acceptance as a standard treatment option is growing.

The aging population and the increasing prevalence of chronic diseases such as liver disease, kidney disease, and lung disorders are further driving demand for microwave ablation. As the global population ages, the incidence of conditions that may lead to tumor development, such as cirrhosis and hepatitis, is rising. For many older patients or those with comorbidities, microwave ablation offers a safer, less invasive option compared to more aggressive surgical interventions. The growing number of patients with chronic diseases and comorbidities is expected to drive further adoption of MWA in oncology and other therapeutic areas.

In conclusion, the microwave ablation market is poised for significant growth driven by the rising global cancer burden, the increasing demand for minimally invasive treatments, and ongoing technological advancements that improve the safety, precision, and efficacy of the procedure. As healthcare providers continue to prioritize patient-centered, cost-effective treatments, the demand for microwave ablation is expected to flourish in the coming years, expanding its role in cancer treatment and beyond.

SCOPE OF STUDY:

The report analyzes the Microwave Ablation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Angio Dynamics
  • Boston Scientific Corporation
  • Emblation microwave
  • Huber+Suhner
  • Johnson & Johnson Services Inc.
  • Med Waves
  • Medtronic PLC
  • MedWaves Inc.
  • Miramar labs
  • Neu Wave Medical
  • Pearson Medical
  • Symple Surgical
  • Urologix
  • Vison Medical USA Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Microwave Ablation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Propels Market Growth for Microwave Ablation Technologies
    • Increasing Adoption of Image-Guided Procedures Strengthens Business Case for Microwave Ablation
    • Rising Demand for Outpatient and Ambulatory Surgery Centers Bodes Well for Microwave Ablation Market Growth
    • Technological Innovations in Microwave Energy Delivery Systems Generate Market Growth
    • Increasing Use of Microwave Ablation in Cardiology Procedures Propels Demand
    • Increasing Adoption of Microwave Ablation for Pain Management Strengthens Market Opportunities
    • Growing Popularity of Microwave Ablation as a Treatment for Varicose Veins Spurs Market Growth
    • Advances in Microwave Antennas and Energy Distribution Propel Adoption in Surgical Procedures
    • Expanding Research in Microwave Ablation for Cardiac Arrhythmias Generates Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Microwave Ablation Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Microwave Ablation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Spain 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Russia 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of Europe 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Microwave Ablation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Australia 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: India 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: South Korea 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Microwave Ablation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Argentina 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Brazil 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Mexico 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Latin America 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Microwave Ablation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Iran 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Israel 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Saudi Arabia 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UAE 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Middle East 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Africa 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION